Quantitative Models in Life Science Business  From Value Creation to Business Processes /  [electronic resource] : 
edited by Jung Kyu Canci, Philipp Mekler, Gang Mu. 
 - 1st ed. 2023. 
 - IX, 127 p. 25 illus., 13 illus. in color.  online resource. 
 - SpringerBriefs in Economics,  2191-5512 .
 - SpringerBriefs in Economics, .
<br/><br/>Part I. Value Creation and Managing Intellectual Property in the Life Science Industry -- Chapter 1. Value Creation, Valuation and Business Models in the Pharmaceutical Sector -- Chapter 2. Alternative Licensing Strategies: A Piecewise Deterministic Differential Game -- Chapter 3. Partnership Models for R&D in the Pharmaceutical Industry -- Part II. Modelling Specific Business Processes in the Life Science Industry -- Chapter 4. Pharma Tender Processes: Modelling Auction Outcomes -- Chapter 5. Multi-Echelon Inventory Optimization Using Deep Reinforcement Learning -- Part III. Specialized Quantitative Tools in the Life Science Industry -- Chapter 6. Stochastic Differential Equations in Healthcare -- Chapter 7. Point Processes with Mixed Doubly Stochastic Poisson and Self-Exciting Flavors: An Excursion Into DALY Computations. 
<br/><br/> Open Access 
<br/><br/> This open access book explores the field of life science business from a multidisciplinary perspective. Applying statistical, mathematical, game-theoretic, and data science tools to pharmaceutical and biotechnology business endeavors, the book describes value creation, value maintenance, and value realization in the life sciences as a sequence of processes using the quantitative language of applied mathematics. Written by experts from a variety of fields, the contributions illustrate the shift from a deterministic to a stochastic view of the processes involved, offering a new perspective on life sciences economics. The book covers topics such as valuing and managing intellectual property in life science, licensing in the pharmaceutical business, outsourcing pharmaceutical R&D, and stochastic modelling of a pharmaceutical supply chain. The book will appeal to scholars of economics and the life sciences, as well as to professionals in chemical and pharmaceutical industries. . 
<br/><br/><label>ISBN: </label>9783031118142 
<br/><br/><label>Standard No.: </label>10.1007/978-3-031-11814-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Medical economics.<br/>Pharmaceutical chemistry.<br/>Technological innovations.<br/>Medicine--Research.<br/>Biology--Research.<br/>Biotechnology.<br/>Econometrics.<br/>Health Economics.<br/>Pharmaceutics.<br/>Economics of Innovation.<br/>Biomedical Research.<br/>Biotechnology.<br/>Quantitative Economics.
<br/><br/><label>LC Class. No.: </label>RA410-410.9 
<br/><br/><label>Dewey Class. No.: </label>338.4761